Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline
The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Abstract
OBJECTIVE The aim was to update The Endocrine Society Clinical Practice Guideline on Evaluation and Treatment of Adult Growth Hormone Deficiency (GHD) previously published in 2006. CONSENSUS PROCESS Consensus was guided by systematic reviews of evidence and discussions through a series of conference calls and e-mails. An initial draft was prepared by the Task Force, with the help of a medical writer, and reviewed and commented on by members of The Endocrine Society. A second draft was reviewed and approved by The Endocrine Society Council. At each stage of review, the Task Force received written comments and incorporated substantive changes. CONCLUSIONS GHD can persist from childhood or be newly acquired. Confirmation through stimulation testing is usually required unless there is a proven genetic/structural lesion persistent from childhood. GH therapy offers benefits in body composition, exercise capacity, skeletal integrity, and quality of life measures and is most likely to benefit those patients who have more severe GHD. The risks associated with GH treatment are low. GH dosing regimens should be individualized. The final decision to treat adults with GHD requires thoughtful clinical judgment with a careful evaluation of the benefits and risks specific to the individual.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GHD in particular has a wide range of test methodology and diagnostic thresholds employed across studies, despite agreement among global guidelines [26 · , 64-67] as to what constitutes deficiency.”
From Neuroendocrine Disruptions Following Head Injury (2023) · cites this paper as [65]
In the citing paper
“For the diagnosis of TBI-induced GHD, the ITT and the GHRHϩARG test are now considered as the tests of choice with similar accuracy (194,215).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
In the citing paper
“The glucagon stimulation test (GST) (1 mg glucagon im, GH measurements every 30 min until 240 min after administration) has been proposed as an alternative diagnostic because it is able to differentiate between GH-deficient and healthy subjects with a sensitivity and specificity of 100% if a peak GH of 3 g/L is considered (215, 226).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
In the citing paper
“For the ITT, peak GH response levels lower than 3 g/L indicate severe GHD in adults (if hypoglycemia is adequately reached) (194,215).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
In the citing paper
“Therefore, in the latest Endocrine Society guideline on the evaluation and treatment of adult GHD, as part of their standard clinical care, patients with severe GHD (diagnosed by appropriate dynamic tests and with relevant clinical features) were recommended individualized physiological doses of recombinant GH treatment (215).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Gamma knife radiosurgery for trigeminal neuralgia associated with multiple sclerosis
Rogers, L., Shetter, A. G., Ponce, F. A., Fiedler, J. A., Smith, K. A., & Speiser, B. L. (2002) · Journal of neurosurgery · doi:10.3171/jns.2002.97.supplement_5.0529 · Cited by 1,773
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402 · cited 1×
“hypogonadal men received testosterone replacement (154).”
Salomon, F., Cuneo, R. C., Hesp, R., & Sönksen, P. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912283212605 · Cited by 1,326
The Role of Carotid Arterial Intima-Media Thickness in Predicting Clinical Coronary Events
Hodis, H. N., Mack, W. J., LaBree, L., Selzer, R. H., Liu, C.-R., Liu, C.-H., & Azen, S. P. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-4-199802150-00002 · Cited by 1,217 · cited 1×
“In epidemiological studies, increases in IMT have predicted the development of symptomatic coronary disease occurring approximately 8 yr after the initial measurements (137).”
Association between premature mortality and hypopituitarism
Tomlinson, J., Holden, N., Hills, R., Wheatley, K., Clayton, R., Bates, A., Sheppard, M., & Stewart, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04006-x · Cited by 1,006
BENEFICIAL EFFECTS OF GROWTH HORMONE TREATMENT IN GH-DEFICIENT ADULTS
Jørgensen, J. O. L., Thuesen, L., Ingemann-Hansen, T., Pedersen, S. A., Jørgensen, I., Skakkebaek, N. E., & Christiansen, J. S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92328-3 · Cited by 890
Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review
Carroll, P. V., Christ the members of Growth Hormon, E. R., Bengtsson, B. Å., Carlsson, L., Christiansen, J. S., Clemmons, D., Hintz, R., Ho, K., Laron, Z., Sizonenko, P., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4594 · Cited by 822
Self-citationTreatment of adults with growth hormone (GH) deficiency with recombinant human GH.
Bengtsson, B. A., Edén, S., Lönn, L., Kvist, H., Stokland, A., Lindstedt, G., Bosaeus, I., Tölli, J., Sjöström, L., & Isaksson, O. G. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.2.8432773 · Cited by 778
Clinical Aspects of Growth Hormone Deficiency in Adults
BOER, H. D., BLOK, G.-J., & DER VEEN, E. A. V. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-63 · Cited by 723
Cited by
Items 101–200 of 1,000
How we treat endocrine complications of immune checkpoint inhibitors
Paschou, S. Α., Stefanaki, K., Ψαλτοπούλου, Θ., Liontos, M., Koutsoukos, K., Zagouri, F., Lambrinoudaki, I. V., & Dimopoulos, M. A. (2021) · ESMO Open · doi:10.1016/j.esmoop.2020.100011 · Cited by 81
The Endocrine Society Guidelines: When the Confidence Cart Goes Before the Evidence Horse
Brito, J. P., Domecq, J. P., Murad, M. H., Guyatt, G. H., & Montori, V. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1814 · Cited by 73
Klose, M., Stochholm, K., Janukonyté, J., Lehman Christensen, L., Frystyk, J., Andersen, M., Laurberg, P., Christiansen, J. S., & Feldt-Rasmussen, U. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2397 · Cited by 73
“6) Waist 102 cm (men) or 88 cm (women), n (%) 119 (27) 22 (18) Tests performed, n (%) ITT (single test) 29 (7) 0 (0) PD-GHRH (single test) 200 (45) 4 (3) GHRH-arg (single test) 37 (8) 1 (1) ITT plus PD-GHRH 156 (36) 79 (64) ITT plus GHRH-arg 15 (3) 31 (25) ITT plus PD-GHRH plus GHRH-arg 0 (0) 9 (7)”
InfluentialLipoatrophy in GH deficient patients treated with a long-acting pegylated GH
Touraine, P. A., D'Souza, G., KOURIDES, I. A., Abs, R., Barclay, P. L., Xie, R., Pico, A. M., Torres-Vela, E. M., & Ekman, B. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0422 · Cited by 79
Acromegaly per se does not increase the risk for coronary artery disease
Akutsu, H., Kreutzer, J., Wasmeier, G. H., Ropers, D., Rost, C., Möhlig, M., Wallaschofski, H., Buchfelder, M., & Schöfl, C. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0945 · Cited by 77
Yuen, K. C. J., Tritos, N. A., Samson, S. L., Hoffman, A. R., & Katznelson, L. (2016) · Endocrine Practice · doi:10.4158/ep161407.dscr · Cited by 73
Johannsson, G., Feldt-Rasmussen, U., Håkonsson, I. H., Biering, H., Rodien, P., Tahara, S., Toogood, A., Rasmussen, M. H., _, _., _, _., et al. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-1073 · Cited by 73
Anthony, J. R., Esper, G. J., & Ioachimescu, A. G. (2015) · Pituitary · doi:10.1007/s11102-015-0678-x · Cited by 72
Tanrıverdi, F., Dökmetaş, H. S., Kebapçı, N., Kilicli, F., Atmaca, H. N., Yarman, S., Ertörer, M. E., Ertürk, E., Bayram, F., Tuğrul, A., et al. (2013) · Endocrine · doi:10.1007/s12020-013-0127-4 · Cited by 80
Nonfunctioning pituitary tumors
Molitch, M. E. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59602-4.00012-5 · Cited by 73
Self-citationThe metabolic effects of growth hormone in adipose tissue
Chaves, V. E., Júnior, F. M., & Bertolini, G. L. (2013) · Endocrine · doi:10.1007/s12020-013-9904-3 · Cited by 77
Growth hormone assays: current methodologies and their limitations
Bidlingmaier, M., & Strasburger, C. J. (2007) · Pituitary · doi:10.1007/s11102-007-0030-1 · Cited by 71
The Changing Face of Sheehan’s Syndrome
Tessnow, A. H., & Wilson, J. D. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181f8c6df · Cited by 70
Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors
van Iersel, L., Mulder, R. L., Denzer, C., Cohen, L. E., Spoudeas, H. A., Meacham, L. R., Sugden, E., Schouten-van Meeteren, A. Y. N., Hoving, E. W., Packer, R. J., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab040 · Cited by 66
Growth Hormone Perturbations in Fibromyalgia: A Review
Jones, K. D., Deodhar, P., Lorentzen, A., Bennett, R. M., & Deodhar, A. A. (2007) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2006.09.006 · Cited by 81
Growth hormone in fertility and infertility: Mechanisms of action and clinical applications
Chang, C., Sung, Y.-W., Hsueh, Y., Chen, Y., Ho, M., Hsu, H.-C., Yang, T., Lin, W.-C., & Chang, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1040503 · Cited by 78
History of growth hormone therapy
Ayyar, V. S. (2011) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.84852 · Cited by 67
Postoperative assessment of the patient after transsphenoidal pituitary surgery
Ausiello, J. C., Bruce, J. N., & Freda, P. U. (2008) · Pituitary · doi:10.1007/s11102-008-0086-6 · Cited by 76
Jørgensen, A. P., Fougner, K. J., Ueland, T., Gudmundsen, O., Burman, P., Schreiner, T., & Bollerslev, J. (2011) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2011.01.001 · Cited by 67
Growth hormone deficiency in the adult
Doga, M., Bonadonna, S., Gola, M., Mazziotti, G., & Giustina, A. (2006) · Pituitary · doi:10.1007/s11102-006-0410-y · Cited by 70
Anatomy, Physiology, and Laboratory Evaluation of the Pituitary Gland
Hong, G. K., Payne, S. C., & Jane, J. A. (2015) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2015.09.002 · Cited by 74
Gasco, V., Cambria, V., Bioletto, F., Ghigo, E., & Grottoli, S. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.634415 · Cited by 63
Mo, D., Fleseriu, M., Qi, R., Jia, N., Child, C. J., Bouillon, R., & Hardin, D. S. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00098-4 · Cited by 64
Simsek, Y., Karaca, Z., Tanriverdi, F., Unluhizarci, K., Selcuklu, A., & Kelestimur, F. (2015) · Clinical Endocrinology · doi:10.1111/cen.12528 · Cited by 64
Status of long-acting-growth hormone preparations — 2015
Höybye, C., Cohen, P., Hoffman, A. R., Ross, R. J. M., Biller, B. M. K., & Christiansen, J. S. (2015) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2015.07.004 · Cited by 67
Alexandraki, K., & Grossman, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122153 · Cited by 62
Deal, C., Hasselmann, C., Pfäffle, R. W., Zimmermann, A. G., Quigley, C. A., Child, C. J., Shavrikova, E. P., Cutler Jr., G. B., & Blum, W. F. (2013) · Hormone Research in Paediatrics · doi:10.1159/000350829 · Cited by 61
Webb, S. M., Strasburger, C. J., Mo, D., Hartman, M. L., Melmed, S., Jung, H., Blum, W. F., Attanasio, A. F., & on behalf of the HypoCCS International Advisory Board (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0713 · Cited by 59
Bagnasco, F., Iorgi, N. D., Roveda, A., Gallizia, A., Haupt, R., & Maghnie, M. (2017) · Endocrine Practice · doi:10.4158/ep171786.or · Cited by 60
The Burden of Hormonal Disorders: A Worldwide Overview With a Particular Look in Italy
Crafa, A., Calogero, A. E., Cannarella, R., Mongioì, L. M., Condorelli, R. A., Greco, E. A., Aversa, A., & Vignera, S. L. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.694325 · Cited by 77
“Finally, thyroid and adrenal functions should also be monitored because GH treatment may lead to a decrease in free thyroxine and cortisol serum levels (19).”
BackgroundPrimary "Empty Sella" in Adults: Endocrine Findings
Monte, P. D., Foppiani, L., CAFFERATA, C., Marugo, A., & Bernasconi, D. (2006) · Endocrine Journal · doi:10.1507/endocrj.k06-024 · Cited by 60
Idiopathic adult growth hormone deficiency
Melmed, S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4012 · Cited by 58
Stanley, T. L., & Grinspoon, S. K. (2014) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2014.12.005 · Cited by 66
Adult GH deficiency throughout lifetime
Thomas, J. D. J., & Monson, J. P. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0258 · Cited by 58
Pituitary Physiology and Diagnostic Evaluation
Melmed, S. K., Kleinberg, D. L., & Ho, K. K. Y. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00008-0 · Cited by 64
Normal values of serum IGF-1 in adults: results from a Brazilian population
Rosario, P. W. (2010) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302010000500008 · Cited by 57
Faje, A. T., & Barkan, A. L. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2634 · Cited by 57
Surface plasmon resonance biosensor for direct detection of antibodies against human growth hormone
Kausaite‐Minkstimiene, A., Ramanavičienė, A., & Ramanavičius, A. (2009) · The Analyst · doi:10.1039/b907315a · Cited by 57
Ross, R. L., Jones, K. D., Bennett, R. M., Ward, R. L., Druker, B. J., & Wood, L. J. (2010) · The Open Immunology Journal · doi:10.2174/1874226201003010009 · Cited by 57
Sattler, F., Bhasin, S., He, J., Chou, C.-P., Castaneda-Sceppa, C., Yarasheski, K., Binder, E., Schroeder, E. T., Kawakubo, M., Zhang, A., et al. (2011) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glq183 · Cited by 57
Predictors of Hypopituitarism in Patients with Traumatic Brain Injury
Silva, P. P. B., Bhatnagar, S., Herman, S. D., Zafonte, R., Klibanski, A., Miller, K. K., & Tritos, N. A. (2015) · Journal of Neurotrauma · doi:10.1089/neu.2015.3998 · Cited by 57
High Prevalence of Growth Hormone Deficiency in Severe Fibromyalgia Syndromes
Cuatrecasas, G., Gonzalez, M. J., Alegre, C., Sesmilo, G., Fernandez-Solà, J., Casanueva, F. F., Garcia-Fructuoso, F., Poca-Dias, V., Izquierdo, J. P., & Puig-Domingo, M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0061 · Cited by 58
Impact of adult growth hormone deficiency on metabolic profile and cardiovascular risk [Review]
Giovannini, L., Tirabassi, G., Muscogiuri, G., Somma, C. D., Colao, A., & Balercia, G. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej15-0337 · Cited by 64
Growth hormone replacement throughout life: Insights into age-related responses to treatment
Clayton, P., Gleeson, H. K., Monson, J. P., POPOVIC, V. M., Shalet, S. M., & Christiansen, J. S. (2007) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2007.04.010 · Cited by 59
Problems with GH assays and strategies toward standardization
Bidlingmaier, M. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0284 · Cited by 56
Growth Hormone Deficiency Following Traumatic Brain Injury
Kgosidialwa, O., Hakami, O., Zia-Ul-Hussnain, H. M., & Agha, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133323 · Cited by 48
“It is well established that patients with GHD from non-traumatic causes benefit from treatment with rhGH [81,82].”
BackgroundTraumatic brain injuries induced pituitary dysfunction: a call for algorithms
Gilis-Januszewska, A., Kluczyński, Ł., & Hubalewska-Dydejczyk, A. (2020) · Endocrine Connections · doi:10.1530/ec-20-0117 · Cited by 50
Progression from isolated growth hormone deficiency to combined pituitary hormone deficiency
Cerbone, M., & Dattani, M. (2017) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2017.10.005 · Cited by 60
Aulinas, A., Plessow, F., Asanza, E., Silva, L., Marengi, D. A., Fan, W., Abedi, P., Verbalis, J., Tritos, N. A., Nachtigall, L., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02608 · Cited by 54
Yuen, K. C. J., Cook, D. M., Sahasranam, P., Patel, P., Ghods, D. E., Shahinian, H. K., & Friedman, T. C. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03201.x · Cited by 53
Endocrine Complications of Hematopoietic Stem Cell Transplantation
Chemaitilly, W., & Sklar, C. A. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.07.002 · Cited by 58
Sistema endocrino y corazón: una revisión
Rhee, S. S., & Pearce, E. N. (2011) · Revista Española de Cardiología · doi:10.1016/j.recesp.2010.10.015 · Cited by 56
Rutter, M. M., Collins, J. J., Rose, S. R., Woo, J. G., Sucharew, H. J., Sawnani, H., Hor, K. N., Cripe, L. H., & Wong, B. L. Y. (2012) · Neuromuscular Disorders · doi:10.1016/j.nmd.2012.07.009 · Cited by 55
“Aside from growth actions, in adults and children not on glucocorticoid treatment who have growth hormone deficiency or other conditions, growth hormone may increase muscle mass and strength, decrease fat mass, and be anabolic for bone [11–18].”
BackgroundThe Use and Abuse of Human Growth Hormone in Sports
Siebert, D. M., & Rao, A. L. (2018) · Sports Health: A Multidisciplinary Approach · doi:10.1177/1941738118782688 · Cited by 52
Endocrine Disorder in Patients With Craniopharyngioma
Zhou, Z., Zhang, S., & Hu, F. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.737743 · Cited by 48
Macario, E. (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s3247 · Cited by 55
van der Eerden, A. W., Twickler, M. T. B., Sweep, F. C. G. J., Beems, T., Hendricks, H. T., Hermus, A. R. M. M., & Vos, P. E. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0436 · Cited by 51
Tritos, N. A., Yuen, K. C. J., & Kelly, D. F. (2015) · Endocrine Practice · doi:10.4158/ep14567.dscr · Cited by 51
Kılıçlı, F., Dökmetaş, H. S., & Acıbucu, F. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.752454 · Cited by 59
Yuen, K. C. J., Biller, B. M. K., Katznelson, L. J., Rhoads, S. A., Gurel, M. H., Chu, O. S., Corazzini, V., Spiller, K., Gordon, M. B., Salvatori, R., et al. (2012) · Pituitary · doi:10.1007/s11102-012-0407-7 · Cited by 54
“The insulin tolerance test (ITT) is considered the gold standard test in assessing GH reserve in adults, while the GHRH-arginine test has been endorsed by several consensus guidelines [1–3] as the main alternative when the ITT is contraindicated, with the exception of recent hypothalamic GH deficiency (GHD) [4].”
MethodImpact of Growth Hormone (GH) Deficiency and GH Replacement upon Thymus Function in Adult Patients
Morrhaye, G., Kermani, H., Legros, J.-J., Baron, F., Beguin, Y., Moutschen, M., Cheynier, R., Martens, H. J., & Geenen, V. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005668 · Cited by 51
Fukuoka, H. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2014.10.011 · Cited by 50
Pregnancy outcomes in women with growth hormone deficiency
Vila, G., Akerblad, A.-C., Mattsson, A. F., Riedl, M., Webb, S. M., Hána, V., Nielsen, E. H., Biller, B. M. K., & Luger, A. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.07.1132 · Cited by 50
Diagnosis and management of prolactinomas and non-functioning pituitary adenomas
Rogers, A., Karavitaki, N., & Wass, J. A. H. (2014) · BMJ · doi:10.1136/bmj.g5390 · Cited by 50
Moore, W. V., Nguyen, H. J., Kletter, G. B., Miller, B. S., Rogers, D. G., Ng, D., Moore, J. A., Humphriss, E., Cleland, J. L., & Bright, G. M. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3279 · Cited by 50
The current state of long-acting growth hormone preparations for growth hormone therapy
Yuen, K. C. J., Miller, B. S., & Biller, B. M. K. (2018) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000416 · Cited by 52
Current concepts of the diagnosis of adult growth hormone deficiency
Tritos, N. A., & Biller, B. M. K. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09594-1 · Cited by 55
Yuen, K. C. J., Conway, G. S., POPOVIC, V. M., Merriam, G. R., Bailey, T. S., Hamrahian, A. H., Biller, B. M. K., Kipnes, M. S., Moore, J. A., Humphriss, E., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1437 · Cited by 54
Self-citationCentral adrenal insufficiency: open issues regarding diagnosis and glucocorticoid treatment
Ceccato, F., & Scaroni, C. (2019) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2018-0824 · Cited by 49
“ITT could be used also to assess the integrity of somatotroph function; however, other tests are suggested to diagnose GH deficiency [64, 65].”
BackgroundGalli, G., Pinchera, A., Piaggi, P., Fierabracci, P., Giannetti, M., Querci, G., Scartabelli, G., Manetti, L., Ceccarini, G., Martinelli, S., et al. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0669-1 · Cited by 57
van der Klaauw, A. A., Romijn, J. A., Biermasz, N. R., Smit, J. W. A., van Doorn, J., Dekkers, O. M., Roelfsema, F., & Pereira, A. M. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02283 · Cited by 49
Krusenstjerna-Hafstrøm, T., Clasen, B. F., Møller, N., Jessen, N., Pedersen, S. B., Christiansen, J. S., & Jørgensen, J. O. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0273 · Cited by 51
Strasburger, C. J., Vaňuga, P., Payer, J., Pfeifer, M., POPOVIC, V. M., Bajnok, L., Góth, M., Olšovská, V., Trejbalová, L., Vadász, J., et al. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0748 · Cited by 54
Chronic endocrine consequences of traumatic brain injury — what is the evidence?
Klose, M., & Feldt-Rasmussen, U. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.103 · Cited by 41
Mazziotti, G., Bianchi, A., Cimino, V., Bonadonna, S., Martini, P. R., Fusco, A., Marinis, L. D., & Giustina, A. (2007) · Pituitary · doi:10.1007/s11102-007-0069-z · Cited by 48
Evaluation of growth hormone stimulation testing in children
Chesover, A. D., & Dattani, M. T. (2016) · Clinical Endocrinology · doi:10.1111/cen.13035 · Cited by 47
Follin, C., Thilén, U., Österberg, K., Björk, J., & Erfurth, E. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0117 · Cited by 50
Capatina, C., Christodoulides, C., Fernandez, A., Cudlip, S., Grossman, A. B., Wass, J. A. H., & Karavitaki, N. (2013) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04449.x · Cited by 45
Biological Rhythms, Drug Delivery, and Chronotherapeutics
Smolensky, M. H., Siegel, R. A., Haus, E. L., Hermida, R. C., & Portaluppi, F. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0881-9_13 · Cited by 53
Appelman‐Dijkstra, N. M., Claessen, K. M. J. A., Hamdy, N. A. T., Pereira, A. M., & Biermasz, N. R. (2014) · Clinical Endocrinology · doi:10.1111/cen.12493 · Cited by 45
Hoyos, C. M., Killick, R., Keenan, D. M., Baxter, R. C., Veldhuis, J. D., & Liu, P. Y. (2014) · SLEEP · doi:10.5665/sleep.3580 · Cited by 48
Yuen, K. C. J., Koltowska-Häggström, M., Cook, D. M., Fox, J. L., Jönsson, P. J., Geffner, M. E., & Abs, R. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0280 · Cited by 45
Pituitary Medicine From Discovery to Patient-Focused Outcomes
Melmed, S. K. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3653 · Cited by 47
Sagna, Y., Courtillot, C., Drabo, J. Y., Tazi, A., Donadieu, J., Idbaïh, A., Aubart, F. C., Amoura, Z., Haroche, J., & Touraine, P. A. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0177 · Cited by 49
Effect of Growth Hormone Replacement on BMD in Adult-Onset Growth Hormone Deficiency
Snyder, P. J., Biller, B. M., Zagar, A., Jackson, I., Arafah, B. M., Nippoldt, T. B., Cook, D. M., Mooradian, A. D., Kwan, A., Scism-Bacon, J., et al. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070205 · Cited by 45
Impaired Pituitary Axes Following Traumatic Brain Injury
Scranton, R., & Baskin, D. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4071463 · Cited by 44
Physical exercise, nutrition and hormones: three pillars to fight sarcopenia
Sgrò, P., Sansone, M., Sansone, A., Sabatini, S., Borrione, P., Romanelli, F., & Luigi, L. D. (2018) · The Aging Male · doi:10.1080/13685538.2018.1439004 · Cited by 54
The frequency and the diagnosis of pituitary dysfunction after traumatic brain injury
Glynn, N., & Agha, A. (2019) · Pituitary · doi:10.1007/s11102-019-00938-y · Cited by 36
di Iorgi, N., Secco, A., Napoli, F., Tinelli, C., Calcagno, A., Fratangeli, N., Ambrosini, L., Rossi, A., Lorini, R., & Maghnie, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1081 · Cited by 44
Wilson, C. L., Chemaitilly, W., Jones, K., Kaste, S. C., Srivastava, D. K., Ojha, R. P., Yasui, Y., Pui, C., Robison, L. L., Hudson, M. M., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.9525 · Cited by 46
IGF-I measurements in the diagnosis of adult growth hormone deficiency
Kwan, A. Y. M., & Hartman, M. L. (2007) · Pituitary · doi:10.1007/s11102-007-0028-8 · Cited by 45
Excess growth hormone suppresses DNA damage repair in epithelial cells
Chesnokova, V., Zonis, S., Barrett, R. J., Kameda, H., Wawrowsky, K., Ben-Shlomo, A., Yamamoto, M., Gleeson, J. P., Bresee, C. J., Gorbunova, V. A., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.125762 · Cited by 49
Laboratory investigations in the diagnosis and follow-up of GH-related disorders
Schilbach, K., & Bidlingmaier, M. (2019) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000192 · Cited by 46
Diagnosis of adult GH deficiency
Gasco, V., Corneli, G., Rovere, S., Croce, C., Beccuti, G., Mainolfi, A., Grottoli, S., Aimaretti, G., & Ghigo, E. (2008) · Pituitary · doi:10.1007/s11102-008-0110-x · Cited by 41
Impact of the growth hormone replacement on bone status in growth hormone deficient adults
Kužma, M., Kužmová, Z., Zelinková, Z., Killinger, Z., Vaňuga, P., Lazurová, I., Tomková, S., & Payer, J. (2014) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2013.12.001 · Cited by 43
Yang, A., Cho, S. Y., Kwak, M. J., Kim, S. J., Park, S. W., Jin, D., & Lee, J. E. (2019) · Scientific Reports · doi:10.1038/s41598-019-52644-1 · Cited by 42
Losa, M., Castellino, L., Pagnano, A., Rossini, A., Mortini, P., & Lanzi, R. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa089 · Cited by 42
Managing Ipilimumab-Induced Hypophysitis: Challenges and Current Therapeutic Strategies
Tsoli, M., Kaltsas, G., Angelousi, A. G., Alexandraki, K., Randeva, H. S., & Kassi, E. N. (2020) · Cancer Management and Research · doi:10.2147/cmar.s224791 · Cited by 43
Brabant, G., Poll, E. M., Jönsson, P., Polydorou, D., & Kreitschmann-Andermahr, I. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0273 · Cited by 41
Growth hormone replacement in adults – current standards and new perspectives
Höybye, C., & Christiansen, J. S. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.09.006 · Cited by 42
Metadata
- Authors
- Molitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L.
- Affiliations
- Northwestern University (US)
- University of North Carolina at Chapel Hill (US)
- University of Washington (US)
- University of Virginia (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-06
- Volume
- 96
- Issue
- 6
- Pages
- 1587-1609
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2090627812
- Semantic Scholar
- 82180f0f73f275a6a0e865c2c46af465e9dc1fc8
- Cited by
- 1,047
- References
- 207
- Citations by year
- 2026: 31 · 2025: 43 · 2024: 46 · 2023: 53 · 2022: 59 · 2021: 61 · 2020: 59 · 2019: 59 · 2018: 64 · 2017: 56 · 2016: 66 · 2015: 63 · 2014: 61 · 2013: 75 · 2012: 42
- FWCI
- 57.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- adult growth hormone deficiency, growth hormone therapy, body composition, exercise capacity, skeletal integrity, quality of life, treatment risks and benefits
- MeSH terms
- Adult, Dwarfism, Pituitary, Humans, Evidence-Based Medicine, Human Growth Hormone, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.